Hennion & Walsh Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-75,787	Closed	-$380K	–	844
2024 Q1	$380K	Buy	75,787 +5,043	+7%	+$34.2K	0.02%	639
2023 Q4	$636K	Buy	70,744 +8,658	+14%	+$71.3K	0.04%	511
2023 Q3	$482K	Buy	62,086 +2,465	+4%	+$24.1K	0.03%	529
2023 Q2	$577K	Sell	59,621 -99,888	-63%	-$1.04M	0.03%	475
2023 Q1	$1.75M	Sell	159,509 -5,302	-3%	-$46.7K	0.11%	232
2022 Q4	$712K	Sell	164,811 -136,874	-45%	-$794K	0.04%	409
2022 Q3	$2.27M	Buy	301,685 +3,637	+1%	+$31.5K	0.15%	178
2022 Q2	$3M	Buy	298,048 +32,450	+12%	+$363K	0.19%	140
2022 Q1	$3.29M	Sell	265,598 -4,407	-2%	-$68.1K	0.17%	158
2021 Q4	$6.17M	Sell	270,005 -10,916	-4%	-$259K	0.3%	89
2021 Q3	$6.22M	Buy	280,921 +24,378	+10%	+$387K	0.33%	71
2021 Q2	$3.33M	Buy	256,543 +82,983	+48%	+$1.06M	0.18%	161
2021 Q1	$2.25M	Buy	+173,560	New	+$2.52M	0.14%	208